Skip to Main Content

Author Details

James P Basilion
Case Western Reserve University
1985
87
36
PMIDPaper TitleJournal TitlePublished Year
36002710Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.Mol Imaging Biol2023
37745586Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.bioRxiv2023
38029329Correction to "Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation".ACS Nano2023
37191680GCP III is not the "off-target" for urea-based PSMA ligands.Eur J Nucl Med Mol Imaging2023
37211857Evaluation of a photodynamic therapy agent using a canine prostate cancer model.Prostate2023
35167141Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit.Prostate2022
35884520Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity.Cancers (Basel)2022
35316026Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.ACS Appl Mater Interfaces2022
35223380Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability <i>in vivo</i> and <i>in vitro</i>.Nanotheranostics2022
35265213A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer.Theranostics2022
33421750Development of near-infrared imaging agents for detection of junction adhesion molecule-A protein.Transl Oncol2021
33920453Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis.Cancers (Basel)2021
33633232Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.Sci Rep2021
33499427Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer.Cancers (Basel)2021
34612645Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent.J Am Chem Soc2021
34203805Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers.Cancers (Basel)2021
32132111A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision.Cancer Res2020
31719100Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.Cancer Res2020
33090762Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation.ACS Nano2020
32845644Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer.Nano Lett2020
32348874Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.Nanomedicine2020
30601524Sink or float? Characterization of shell-stabilized bulk nanobubbles using a resonant mass measurement technique.Nanoscale2019
31588336Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?Chem Sci2019
31265213Targeted Gold Nanocluster-Enhanced Radiotherapy of Prostate Cancer.Small2019
30915384Molecular imaging and validation of margins in surgically excised nonmelanoma skin cancer specimens.J Med Imaging (Bellingham)2019
29641905Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.ACS Nano2018
27876303Rapid visualization of nonmelanoma skin cancer.J Am Acad Dermatol2017
28271367Optical Surgical Navigation for Precision in Tumor Resections.Mol Imaging Biol2017
28428283Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection.Cancer Res2017
28989616Synthesis and evaluation of MR probes for targeted-reporter imaging.Chem Sci2017
27084431Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor Xenografts.Transl Oncol2016
26449839Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report.J Nucl Med2016
27297866Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.Mol Cancer Ther2016
25775241Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.Bioconjug Chem2015
26435847Molecular Imaging of Tumors Using a Quantitative T 1 Mapping Technique via Magnetic Resonance Imaging.Diagnostics (Basel)2015
25999665Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer.Part Part Syst Charact2015
25627979Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.Cancer Res2015
23934254On-command drug release from nanochains inhibits growth of breast tumors.Pharm Res2014
25238130Biocompatible nanoparticles of KGd(H⿿O)⿿[Fe(CN)⿿]·H⿿O with extremely high T⿁-weighted relaxivity owing to two water molecules directly bound to the Gd(III) center.Langmuir2014
25239933Development of targeted near-infrared imaging agents for prostate cancer.Mol Cancer Ther2014
24705781Microscopic detection of quenched activity-based optical imaging probes using an antibody detection system: localizing protease activity.Mol Imaging Biol2014
22987116Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.Int J Cancer2013
23256496Nanoparticles for imaging and treating brain cancer.Nanomedicine (Lond)2013
22125093Cryo-image analysis of tumor cell migration, invasion, and dispersal in a mouse xenograft model of human glioblastoma multiforme.Mol Imaging Biol2012
22807580An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor.Mol Cancer Ther2012
22505657Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.Neuro Oncol2012
22267545Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.Mol Cancer Res2012
22427947Topical application of activity-based probes for visualization of brain tumor tissue.PLoS One2012
21183793Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.J Clin Invest2011
21862632Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail.Cancer Res2011
  • 1 - 50 of 87

Recommended Authors

Pallavi Jain
SRM Institute of Science and Technology
Career Start Year 2012
Number of shared co-authors 0
Ye Yuan
Southwest Hospital, Army Medical University
Career Start Year 2011
Number of shared co-authors 0
Lei Zhu
Emory University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Fan Zhang
The Second Hospital of Dalian Medical University
Career Start Year 2010
Number of shared co-authors 0
Jeroen A C M Goos
Karolinska Institutet
Career Start Year 2009
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Nimit L Patel
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year 2008
Number of shared co-authors 0
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Seulki Lee
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Career Start Year 2004
Number of shared co-authors 0
Ludwig Dubois
Maastricht University
Career Start Year 2004
Number of shared co-authors 0
Natasja G Lieuwes
Maastricht University
Career Start Year 2003
Number of shared co-authors 0
Gopal Iyer
University of Wisconsin School of Medicine and Public Health, University of Wisconsin
Career Start Year 2002
Number of shared co-authors 0
Hon S Leong
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Hak Soo Choi
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 0
Trevor D McKee
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
Ranjini K Sundaram
Yale University
Career Start Year 1996
Number of shared co-authors 0
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Johnny Do
Stanford University
Career Start Year 1993
Number of shared co-authors 0
Mei He
Sichuan University
Career Start Year 1992
Number of shared co-authors 0
Hisataka Kobayashi
Center for Cancer Research
Career Start Year 1990
Number of shared co-authors 0
Martin W Brechbiel
National Institutes of Health
Career Start Year 1985
Number of shared co-authors 0
Marcelino Bernardo
Center for Interventional Oncology, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 0
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 1
Peter S Conti
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Andrew E Sloan
Co-authored papers 5
Tracey A Rouault
Co-authored papers 4
Dennis C Sgroi
Co-authored papers 2
Laszlo Nagy
University of Debrecen
Co-authored papers 2
Michael Bouvet
Co-authored papers 2
Wadih Arap
Rutgers Cancer Institute of New Jersey
Co-authored papers 1
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 1
David M Koeller
Oregon Health & Science University
Co-authored papers 1
Fernanda I Staquicini
Rutgers Cancer Institute of New Jersey
Co-authored papers 1
Richard L Sidman
Harvard Medical School
Co-authored papers 1
Suren Soghomonyan
The Ohio State University Wexner Medical Center
Co-authored papers 1
Frank B Furnari
University of California San Diego
Co-authored papers 1
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Co-authored papers 1
Kenneth Aldape
National Cancer Institute
Co-authored papers 1
Michael G Ozawa
Stanford University School of Medicine
Co-authored papers 1
Catherine A Moya
Co-authored papers 1
David E Housman
Co-authored papers 1
Mian M Alauddin
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Robert M Hoffman
Co-authored papers 1
Leo G Flores
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 1
Mark L Cohen
Co-authored papers 1
Magnus H????k
Texas A&M Health Science Center Institute of Biosciences and Technology
Co-authored papers 1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 1
Renata Pasqualini
Rutgers Cancer Institute of New Jersey
Co-authored papers 1
Wouter H P Driessen
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Elena M Barbu
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Vincenzo Paolillo
UT MD Anderson Cancer Center
Co-authored papers 1
Release 1.2